Skip to main content

This job has expired

You will need to login before you can apply for a job.

Sr Manager of Investor Relations and FP&A

Employer
4D Molecular Therapeutics
Location
Emeryville, California
Start date
Mar 17, 2023

View more

Discipline
Administration, Accounting, Finance
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Biotech Bay, Best Places to Work

Job Details

4D Molecular Therapeutics, Inc. (“4DMT”) is a clinical-stage genetic medicines company pioneering the development of product candidates using targeted and evolved AAV vectors. 4DMT seeks to unlock the full potential of genetic medicines using its platform, Therapeutic Vector Evolution, which combines the power of directed evolution with approximately one billion synthetic capsid sequences to invent evolved vectors for use in targeted genetic medicine products. The company is initially focused in three therapeutic areas: ophthalmology, pulmonology, and cardiology. The 4DMT targeted and evolved vectors are invented with the goal of being delivered through clinically routine, well-tolerated and minimally invasive routes of administration, transducing diseased cells in target tissues efficiently, having reduced immunogenicity and, where relevant, having resistance to pre-existing antibodies. 4DMT has five active clinical product candidates: 4D-150 is in Phase 1/2 clinical trials for Wet AMD and DME, 4D-710 is in Phase 1/2 clinical trials for Cystic Fibrosis lung disease, 4D-310 is in a Phase 1/2 clinical trial for Fabry disease, 4D-125 is in a Phase 1/2 clinical trial for XLRP, and 4D-110 is in a Phase 1 clinical trial for Choroideremia. In addition, 4DMT has two preclinical products: 4D-175 for geographic atrophy and 4D-725 for AATLD.

  4DMT is focused on attracting and retaining the best people in the industry who identify with our mission and innovative results-driven approach. We offer an inspiring and collaborative environment that encourages individual contributions, recognizes performance in multiple ways, offers competitive salary and benefits, and provides challenging opportunities for career development.  4D Molecular Therapeutics is located in Emeryville, CA.

GENERAL SUMMARY:

As Senior Manager of Investor Relations, Corporate Finance, and FP&A, you will be part of a team that will be responsible for the overall financial strategy and external face of 4DMT. You will play pivotal roles in the capital raising process, valuation of current and future products, annual budgeting process, periodic budget vs actual reporting, investor relations activities, and other ad hoc projects. This position reports to the Head of Investor Relations & Finance and works closely with the Chief Financial Officer and others in senior management. The role will be hybrid (~2-3 days per week in the office).

RESPONSIBILITIES:

  • Work closely with CFO and Head of Investor Relations & Finance to develop the evaluation of strategic and business alternatives
  • Drive the analysis of 4DMT’s capital structure, including supporting evaluation and execution of potential financing transactions (e.g, equity, debt, partnerships etc)
  • Working with the internal strategy and business development teams, to develop financial support processes & valuation for transactions as needed
  • Participate and lead select budgeting, forecasting, and long-range planning activities
  • Prepare and publish monthly reports including budget versus actual comparisons
  • Create Executive and Board level presentations
  • Assist Head of Investor Relations & Finance with Investor Relations activities (e.g., drafting external facing materials such as corporate deck, data disclosure decks, press releases, Investor Day prep, researching peer company disclosures to aid in drafting process, maintaining Wall Street analyst consensus model)
  • Manage ad-hoc requests and analysis to support executive management and finance group

FP&A / Corporate Modeling / Ad Hoc Analysis: 60% of TIME

IR: 30% of TIME

Various other Ad Hoc F&A projects: 10%

QUALIFICATIONS:

Education:

  • Bachelor degree in finance or accounting, with MBA preferred
  • Bachelor degree or MS/PhD in biological sciences (e.g, Biology, Biochemistry, or similar) highly preferred

Experience:

  • 5+ years of relevant work experience (investment banking, management consulting, corporate strategy/finance, etc.) within the life sciences industry
  • Excellent understanding of the biotechnology industry and the various functional areas
  • Evaluating and analyzing complex financing and business initiatives
  • Experience working with Senior Executives
  • Experienced with licensing and business M&A valuation modeling

Skills:

  • Excellent computer skills (Advanced Excel, Word and PowerPoint skills are required)
  • High degree of initiative and ability to work independently
  • Strong interpersonal skills and a team player is essential
  • Excellent written and verbal communication skills; ability to work effectively with Senior Executives and with cross functional counterparts
  • Exceptional problem-solving and quantitative/analytical skills

Physical Requirements of the Role:  primarily computer use

  • To maintain a healthy and safe workplace for all during the COVID-19 this role is expected to:
    • Open to hybrid-based employee with occasional travel (2-3 times a year)
    • Adhere to 4DMT Covid protocols and policy. This includes all employees and contractors must share proof of current vaccination status to work onsite.

 

Base salary compensation range:

 

 

Minimum

Maximum

National Range

$142K

$180K

Bay Area Range

$176K             

$202K

Please note, the base salary compensation range and actual salary offered to the final candidate is dependent on variety of factors: candidate’s geographical location, relevant work experience, skills, and years of experience.

 

 

 

 

4DMT provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, national origin, age, disability, genetic information, marital status, status as a covered veteran, and any other category protected under applicable federal, state, provincial and local laws.   Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities

Company

4DMT is a gene therapy company with a transformative discovery platform --Therapeutic Vector Evolution --that enables our “disease first” approach to product discovery and development, thereby allowing us to customize our AAV vectors to target specific tissue types associated with the underlying disease.


At 4DMT we are creating and developing optimized “biopharmaceutical grade” AAV vectors that will allow us uniquely to unlock the full potential of gene therapy. Our customized and proprietary AAV vectors are each designed, according to a 4DMT Target Vector Profile, to deliver genes to specific cells and tissues in the body to eradicate both rare and large market diseases.


While AAV gene therapy pioneers are making great strides with the first wave of products, hurdles still exist with the use of conventional vectors. The most commonly used AAV capsids (e.g., AAV2, 5, 8 and 9) were identified either 1) as contaminants in lab stocks of adenovirus, or 2) through monkey tissue processing. Therefore, these conventional vectors are not targeted specifically to any tissue in the body. This can lead to inefficient and non-specific delivery, thus requiring extremely high doses and potentially resulting in toxicities (including inflammation), high manufacturing burdens and suboptimal efficacy. In addition, suboptimal routes of delivery can be required for delivery to the right tissues (e.g., subretinal delivery to the retina). Finally, pre-existing neutralizing antibodies in many patients can limit efficacy, clinical trial enrollment and market sizes. 4DMT Innovation empowers us to create new and improved next generation AAV capsids to allow targeted delivery of our products by the optimal clinical route of administration.


At 4DMT we use our robust discovery platform, termed “Therapeutic Vector Evolution,” to create customized and proprietary gene delivery vehicles (novel AAV vectors) to deliver genes to specific tissues and cells in the body by the optimal route of administration. We use the power of evolution to create and refine these optimized vectors through genetic diversification and then natural selection in vivo.


4D Purpose Statement:  Boldly Innovating to Unlock the Full Potential of Gene Therapy for Countless Patients


GUIDING PRINCIPLES

 

  • Dare to Cure - Patients are waiting. Create big dreams for patients and take calculated risks to achieve them
  • Break Boundaries - Question the status quo and innovate beyond conventional approaches
  • Beyond Yourself - It's about patients, their families, our team, our families. We strengthen each other.
  • Prepare and Execute Relentlessly - Start with the end in mind, over-prepare and make contingency plans to your contingency plans


We invite all of you who share our passion and vision in creating the ultimate gene therapy products to cure genetic and rare diseases in children and adults. We seek the best people in the industry who identify with our mission and innovative results-driven approach. We offer an inspiring and collaborative environment that encourages individual contributions, recognizes performance in multiple ways, offers generous benefits and provides challenging opportunities for career development. 
 

Company info
Website
Phone
510-505-2680
Location
5858 Horton St. Suite 455
Emeryville
California
94608
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert